Background Immune checkpoint inhibitors have been widely implemented in current clinical
practice. Although cancer occurs in∼ 1 out of 1000 pregnancies, treatment remains …

Simple Summary In this paper we perform an introduction about pregnancy-associated
cancer (PAC) and transplacental passage of antineoplastic agents. Furthermore, we …

The management of cancer during pregnancy requires a patient-centered, multidisciplinary
approach to balance maternal and fetal well-being given the rarity of this clinical scenario …

Simple Summary Pregnancy-associated breast cancer (PABC) is mainly defined as breast
cancer diagnosed during the gestational period or in the first year after birth. Significant …

Purpose Pregnancy-associated breast cancer (PABC), defined as breast carcinoma
diagnosed during pregnancy or in the first post-partum year, is one of the most common …

Importance Targeted therapies directed against ERBB2 are the cornerstone of medical
treatment for ERBB2-positive breast cancers but are contraindicated during pregnancy …

More than 90% of women with newly diagnosed breast cancer present with stage I to III
disease and, with optimal multidisciplinary therapy, are likely to survive their disease. Of …

Breast cancer is the most common malignancy occurring during gestation. In early-stage
breast cancer during pregnancy (PrBC), breast-conserving surgery (BCS) with delayed RT is …

Introduction For women presenting with breast cancer during pregnancy, treatment
guidelines were historically restricted to only surgical treatment. Over the past decades …

As cardio-oncology imposed itself as the reference specialty for a comprehensive
cardiovascular approach to all patients with cancer, a more specific and careful cardiac …